Related Experiment Videos
Effect of N-acetylcysteine on pulmonary damage due to microembolism in the rat
Abstract:
The effect of N-acetylcysteine (NAC), a free radical scavenger, was investigated in a microembolism rat model of adult respiratory distress syndrome (ARDS). Microembolism was induced by an intravenous injection of bovine thrombin and an intraperitoneal injection of a fibrinolysis inhibitor, trans-4-aminomethyl-cyclohexane-carboxylic acid (AMCA). NAC counteracted the experimentally induced increase in lung weight, the development of alveolar oedema, and the amount of fibrin in precapillary vessels. There was also a tendency to a decrease of the experimentally induced interstitial oedema caused by the NAC treatment, although it was not statistically significant. Surprisingly, NAC reduced plasma viscosity in both experimental and control animals. It also seemed to increase PaO2 in animals with pulmonary damage, but had a lowering effect on PaO2 in control animals. The results indicate that NAC has a significant preventive effect in this microembolism rat model of ARDS, and that this effect may be achieved through decreased deposition of fibrin, thus counteracting pulmonary oedema, and a decrease in plasma viscosity.
Insights
N-acetylcysteine (NAC) shows promise in preventing acute respiratory distress syndrome (ARDS) in a rat model. NAC reduced lung edema and fibrin deposition, also decreasing plasma viscosity.
Area of Science:
- Pulmonary Medicine
- Pharmacology
- Biochemistry
Background:
- Adult respiratory distress syndrome (ARDS) involves lung injury and edema.
- N-acetylcysteine (NAC) is a known free radical scavenger with potential therapeutic properties.
Purpose of the Study:
- To investigate the protective effects of N-acetylcysteine (NAC) in a rat model of microembolism-induced ARDS.
- To evaluate NAC's impact on lung weight, edema, fibrin deposition, and plasma viscosity.
Main Methods:
- ARDS was induced in rats using bovine thrombin and trans-4-aminomethyl-cyclohexane-carboxylic acid (AMCA).
- Animals were treated with N-acetylcysteine (NAC) to assess its effects.
- Measurements included lung weight, alveolar and interstitial edema, fibrin levels, plasma viscosity, and PaO2.
Main Results:
- NAC significantly counteracted increased lung weight and alveolar edema.
- NAC reduced fibrin deposition in lung vessels.
- NAC decreased plasma viscosity and tended to improve oxygenation (PaO2) in ARDS models.
Conclusions:
- N-acetylcysteine (NAC) demonstrates significant preventive effects against microembolism-induced ARDS in rats.
- NAC's benefits may stem from reduced fibrin deposition, counteracting pulmonary edema, and decreasing plasma viscosity.